How to Value an Oral Surgery Practice in 2026

Oral surgery practices occupy a unique space in dental M&A. They're not general dental practices, and applying general dental multiples to an OMS practice is a mistake I see brokers and even some PE firms make regularly. The referral-dependent model, sedation capability, procedure mix, and surgeon training pipeline create a valuation framework that is distinctly its own.

I've worked on oral surgery transactions ranging from solo OMFS practices selling to younger surgeons for $800K to multi-surgeon groups selling to dental-focused PE platforms for $15M+. The spread is enormous, and understanding what drives it is critical whether you're buying or selling.

The Range: 5-10x EBITDA

Oral surgery-only practices trade at 5-10x EBITDA, with the range depending on surgeon count, procedure mix, sedation infrastructure, and the strength of the referring dentist network. Solo practices at the lower end, multi-surgeon groups with owned office surgery suites at the top.

Why EBITDA rather than the collections-based method used for general dental? Because oral surgery practices typically generate $1.5M-$5M+ in revenue with higher overhead structures (anesthesia costs, surgical equipment, malpractice insurance) that make SDE less useful as a comparability metric. Buyers — particularly PE-backed dental platforms — underwrite on EBITDA to normalize across practices with different cost structures.

At the lower end (5-6x), you typically see solo OMS practices where the surgeon is the entire revenue engine, referral sources are concentrated in a handful of dentists, and the practice lease is in a general dental office setting without dedicated surgical infrastructure. At the upper end (8-10x), you're looking at multi-surgeon groups with purpose-built surgical suites, in-house anesthesia capability, 100+ active referring dentists, and consistent implant case volume growth.

Wisdom Teeth and Implant Volume: The Two Revenue Pillars

Oral surgery revenue concentrates in two procedure categories that have very different valuation implications.

Third molar extractions (wisdom teeth) are the volume driver. A busy OMS practice performs 800-1,500+ third molar cases per year, often with 3-4 patients under sedation per morning session. Wisdom teeth provide predictable, insurance-covered revenue with consistent demand — every 17-year-old with impacted wisdom teeth needs the same procedure. The revenue per case is moderate ($1,200-$2,500 depending on complexity and payer), but the volume is reliable.

Dental implants are the margin driver. Single-tooth implants, full-arch implant procedures (All-on-4/All-on-X), and bone grafting cases generate $2,000-$25,000+ per case. Implant work has grown dramatically as patient awareness of implant options increases and referring general dentists increasingly partner with OMS practices for implant placement while retaining the restorative component.

Buyers want to see a healthy mix of both. Practices that are 90%+ wisdom teeth extractions have predictable but limited upside — the procedure mix is commodity-like. Practices with a growing implant component (25-40% of revenue) demonstrate clinical sophistication and higher per-case economics that justify premium multiples.

The trend toward full-arch implant dentistry (Teeth-in-a-Day, All-on-4) has been a significant value creator. OMS practices that have invested in the technology, training, and marketing for full-arch cases are seeing outsized revenue growth and attracting the most aggressive buyer interest.

Sedation and Anesthesia Capability

The ability to provide deep sedation and general anesthesia in-office is what separates oral surgery from other dental specialties and is a core valuation driver. OMFS residency training includes anesthesia rotations specifically because the specialty requires this capability.

Buyers evaluate anesthesia infrastructure closely:

• Anesthesia permits and licensing: State dental board anesthesia permits must be current, with clean inspection history. Any anesthesia-related adverse events or permit restrictions are deal-killers.
• Equipment and monitoring: Modern anesthesia delivery systems, capnography, pulse oximetry, crash cart, and recovery area. Outdated equipment signals capital expenditure needs.
• AAOMS office anesthesia evaluation: Practices that have undergone and passed AAOMS office anesthesia evaluations (OAE) demonstrate a commitment to safety standards that buyers value.
• Anesthesia staffing model: Does the surgeon self-administer with a trained surgical assistant monitoring, or does the practice employ a CRNA or dental anesthesiologist? The latter increases cost but also increases throughput and safety profile.

A practice with a dedicated surgical suite, modern anesthesia capability, and clean safety record is worth meaningfully more than one performing procedures under local anesthesia or basic conscious sedation only. The sedation capability is what enables the high-volume wisdom teeth throughput and complex implant procedures that drive revenue.

The Referring Dentist Network

Oral surgery is a referral-dependent specialty. Unlike general dentists who market directly to patients, OMS practices receive the vast majority of their patients from referring general dentists, pediatric dentists, orthodontists, and periodontists. The referring dentist network is arguably the most valuable intangible asset in any oral surgery practice.

Buyers measure this in concrete terms:

• Number of active referring dentists: "Active" means they've sent at least one referral in the past 12 months. A healthy practice has 80-150+ active referrers. Under 40 is a concentration risk.
• Top-10 referrer concentration: If your top 10 referring dentists account for 50%+ of referrals, that's vulnerability. Ideally, no single referrer represents more than 5-8% of case volume.
• Referral trend: Is the number of active referrers growing or shrinking? Are established referrers sending more or fewer cases year-over-year? New dentists opening practices in your area should be converting into referral sources.

The critical question buyers ask is: will these referring dentists continue sending patients after the practice changes ownership? The answer depends on whether the relationships are personal (Dr. Smith sends cases because he's friends with the selling surgeon) or institutional (dentists refer because the practice provides excellent clinical outcomes, fast turnaround, and good patient communication). Personal relationships are fragile. Institutional relationships transfer.

OMFS Residency Training and Surgeon Pipeline

Oral and maxillofacial surgery residencies are among the most competitive and longest training programs in dentistry — 4-6 years post-dental school, with many programs now dual-degree (DMD/MD or DDS/MD). This creates a structural supply constraint: there are roughly 100 new OMFS graduates per year in the United States, far fewer than the number of retiring surgeons.

This supply-demand imbalance affects valuation in two ways. First, it makes multi-surgeon practices more valuable because replacing a departing surgeon is genuinely difficult — the recruiting pool is small and new graduates have multiple practice opportunities. Second, it creates a natural floor on multiples because the barriers to entry are so high that de novo competition is limited.

Buyers, especially PE platforms, evaluate whether the practice can recruit and retain associate surgeons. A practice with a track record of successfully onboarding associates — with an established associate pathway and buy-in structure — is more scalable and therefore more valuable than one that has never had an associate.

What Kills Oral Surgery Practice Value

Anesthesia incidents. Even a single serious adverse anesthesia event creates enormous liability exposure and can trigger state board investigation, increased malpractice premiums, and reputational damage that directly impacts referrals. Clean anesthesia history is non-negotiable for buyers.

Solo surgeon with no succession plan.A single-surgeon OMS practice is the surgeon. If Dr. Smith retires and there's no associate to maintain continuity, referring dentists may redirect their referrals before a buyer even takes over. Practices without at least a credible succession plan trade at 5-6x versus 7-10x for multi-surgeon groups.

Declining wisdom teeth volume without implant growth.If third molar cases are declining (which happens as demographic patterns shift) and implant volume hasn't grown to compensate, the practice is shrinking. Buyers discount aggressively for declining trajectory.

Insurance-heavy payer mix. Practices where 80%+ of revenue comes from dental insurance plans with negotiated fee schedules face margin compression as insurers ratchet down reimbursement. Practices with meaningful out-of-network or fee-for-service implant revenue are better positioned.

Maximizing Your Oral Surgery Practice Value

Invest in implant capability.If you haven't already, commit to full-arch implant dentistry. The training, CBCT scanner, surgical guides, and marketing investment pay for themselves in revenue growth and valuation premium.

Hire an associate. A practice with two surgeons is worth disproportionately more than twice the value of a solo practice because it demonstrates sustainability. Start the associate search 2-3 years before your target exit.

Systematize referral management. Track every referral source, implement a referring dentist communication system (case updates, post-op reports), and actively cultivate relationships with new dentists in your area. Make the referral relationship institutional, not personal.

Modernize your surgical suite.Current-generation CBCT, digital surgical planning, guided implant placement capability, and modern anesthesia monitoring signal to buyers that they're acquiring a forward-looking practice, not a renovation project.

The Bottom Line

Oral surgery practices are premium assets in the dental M&A market, trading at 5-10x EBITDA based on procedure mix, surgeon depth, anesthesia capability, and referral network strength. The structural supply constraint on OMFS surgeons creates a natural valuation floor, while the shift toward implant dentistry is creating meaningful upside for practices that invest in that capability. The practices commanding the highest multiples in 2026 have multiple surgeons, diversified referral networks, growing implant revenue, and clean anesthesia records. If you're planning an exit, those are the levers that matter.